The Hormone Therapy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the hormone therapy market has significantly increased over the past few years. It stood at $19.7 billion in 2024 and is projected to reach $21.1 billion in 2025 with a CAGR of 7.1%. The historical growth trend in the hormone therapy market is significant.
The hormone therapy market is predicted to reach a valuation of $28.46 billion by 2029, expanding at a compound annual growth rate (CAGR) of 7.8%.
Download Your Free Sample of the 2025 Hormone Therapy Market Report and Uncover Key Trends Now!The key drivers in the hormone therapy market are:
• The rise in personalized medicine approach
• Changing dynamics due to aging population
• A shift in women's health approaches stressing on wellness and longevity
• Regulatory adaptations in the hormone therapy sector
The hormone therapy market covered in this report is segmented –
1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
The key trends in the hormone therapy market are:
• The trend of personalized medicine approach is significantly influencing the future of the hormone therapy market.
• Ongoing changes in women's health approaches and a focus on wellness and longevity are contributing to the evolution of the sector.
• Regulatory changes and guidelines are emerging trends in the forecast period.
• Expanding awareness and education, coupled with advancements in research and development, are shaping the future of the industry.
Major companies in the hormone therapy market are:
• Abbott Laboratories
• Bayer AG
• Eli Lilly and Company
• F. Hoffmann-La Roche
• Merck KGaA
• Mylan NV
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Abbvie Inc.
• Teva Pharmaceutical Industries Ltd.
• Perrigo Company Plc.
• Cipla Inc.
• Lupin Limited
• Sun Pharmaceuticals Industries Ltd.
• Hikma Pharmaceuticals PLC.
• Johnsons & Johnsons Services Inc.
• Boehringer Ingelheim International GmbH
• Sanofi S.A.
• AstraZeneca plc
• TherapeuticsMD Inc.
• Amgen Inc.
• Genentech Inc.
• Dr. Reddy's Laboratories Ltd
• Allergan PLC
• GlaxoSmithKline plc
• Bristol-Myers Squibb Company
• Takeda Pharmaceutical Company Limited
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
North America was the largest region in the hormone therapy market in 2024